Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.600
-0.012 (-1.96%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Cytosorbents Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
3840505868182
Upgrade
Market Cap Growth
-36.02%-19.32%-14.14%-14.31%-62.87%-47.06%
Upgrade
Enterprise Value
6060716858135
Upgrade
Last Close Price
0.600.640.911.111.554.19
Upgrade
PS Ratio
1.021.081.401.861.954.22
Upgrade
PB Ratio
6.386.804.482.471.912.91
Upgrade
P/TBV Ratio
14.0515.006.742.962.183.15
Upgrade
EV/Sales Ratio
1.631.611.992.181.693.12
Upgrade
Debt / Equity Ratio
4.934.932.420.780.520.22
Upgrade
Net Debt / Equity Ratio
3.873.872.130.18-0.11-0.61
Upgrade
Net Debt / EBITDA Ratio
-1.79-1.79-1.59-0.140.131.74
Upgrade
Net Debt / FCF Ratio
-1.82-1.82-1.60-0.190.112.17
Upgrade
Asset Turnover
0.810.810.710.540.450.48
Upgrade
Inventory Turnover
2.642.643.512.673.392.97
Upgrade
Quick Ratio
1.421.421.081.442.864.14
Upgrade
Current Ratio
2.132.132.201.813.484.70
Upgrade
Return on Equity (ROE)
-96.39%-96.39%-119.80%-99.38%-67.00%-34.64%
Upgrade
Return on Assets (ROA)
-19.44%-19.44%-20.50%-34.37%-25.27%-15.84%
Upgrade
Return on Capital Employed (ROCE)
-41.30%-41.30%-43.80%-82.10%-57.70%-30.00%
Upgrade
Earnings Yield
-21.79%-20.42%-41.64%-50.47%-48.51%-13.48%
Upgrade
FCF Yield
-33.34%-31.24%-29.57%-38.29%-50.74%-9.69%
Upgrade
Buyback Yield / Dilution
-14.32%-14.32%-21.90%-2.49%-0.49%-11.70%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.